Advertisement
Advertisement
U.S. Markets open in 8 hrs 41 mins
Advertisement
Advertisement
Advertisement
Advertisement

LIFE Aug 2022 10.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
1.90000.0000 (0.00%)
As of 10:55AM EDT. Market open.
Advertisement
Full screen
Previous Close1.9000
Open1.9000
Bid1.0000
Ask2.1500
Strike10.00
Expire Date2022-08-19
Day's Range1.9000 - 1.9000
Contract RangeN/A
Volume1
Open Interest2
  • GlobeNewswire

    aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2022 Financial Results

    Management to host conference call and webcast on August 15th at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase biology platform, today announced that it will report second quarter 2022 financial results and provide a corporate update after the market close on Monday, August 15, 2022. Management will host a co

  • Simply Wall St.

    Bullish aTyr Pharma, Inc. (NASDAQ:LIFE) insiders filled their treasuries with US$2.1m worth of stock over last year

    Quite a few insiders have dramatically grown their holdings in aTyr Pharma, Inc. ( NASDAQ:LIFE ) over the past 12...

  • GlobeNewswire

    aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment

    Poster to be presented at the Keystone Symposia on Tissue Fibrosis and Repair. Second tRNA synthetase receptor identified from company’s platform. Findings suggest AARS fragment may have therapeutic potential in fibrosis, inflammation and cancer. SAN DIEGO, June 14, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase biology platform, today announced that new

Advertisement
Advertisement